SENSIENT TECHNOLOGIES CORP Income Taxes Disclosure
|
(In thousands)
|
2025
|
2024
|
2023
|
|||||||||
|
United States
|
$
|
66,358
|
$
|
57,318
|
$
|
45,900
|
||||||
|
Foreign
|
111,189
|
105,480
|
83,951
|
|||||||||
|
Total
|
$
|
177,547
|
$
|
162,798
|
$
|
129,851
|
||||||
|
(In thousands)
|
2025
|
2024
|
2023
|
|||||||||
|
Current income tax expense:
|
||||||||||||
|
Federal
|
$
|
13,395
|
$
|
20,307
|
$
|
11,153
|
||||||
|
State
|
1,936
|
3,375
|
2,814
|
|||||||||
|
Foreign
|
30,432
|
33,048
|
27,590
|
|||||||||
|
|
45,763
|
56,730
|
41,557
|
|||||||||
|
Deferred expense (benefit):
|
||||||||||||
|
Federal
|
46
|
(12,743
|
)
|
(4,656
|
)
|
|||||||
|
State
|
(1,338
|
)
|
(581
|
)
|
(813
|
)
|
||||||
|
Foreign
|
(1,413
|
)
|
(5,274
|
)
|
369
|
|||||||
|
|
(2,705
|
)
|
(18,598
|
)
|
(5,100
|
)
|
||||||
|
Income taxes
|
$
|
43,058
|
$
|
38,132
|
$
|
36,457
|
||||||
|
(In thousands)
|
2025
|
|||
| Federal |
$ | 13,686 | ||
| State |
3,211 | |||
| Germany |
7,389 | |||
| Thailand | 4,904 | |||
| Mexico | 3,846 | |||
| China |
3,141 | |||
| France |
2,408 | |||
| Foreign - Other |
10,221 | |||
| Total |
$ | 48,806 | ||
|
|
2025
|
|||||||
|
|
Amount | Percent | ||||||
| Taxes at statutory rate |
$ | 37,285 | 21.0 | % | ||||
| State income taxes, net of federal income tax benefit |
||||||||
|
Wisconsin1
|
(1,053 | ) | (0.6 | ) | ||||
|
Other state income taxes1
|
1,140
|
0.6 | ||||||
| Tax credits |
||||||||
|
Research and Development tax credits
|
(3,674 | ) | (2.1 | ) | ||||
| Foreign tax effects |
||||||||
|
Germany
|
||||||||
|
Foreign statutory tax rate difference
|
(1,622 | ) | (0.9 | ) | ||||
|
Enacted change in tax rate impact on deferred items
|
(1,726 | ) | (1.0 | ) | ||||
|
Local taxes
|
4,039 | 2.3 | ||||||
|
Other foreign jurisdictions
|
6,823 | 3.9 | ||||||
| Effect of cross-border taxes |
||||||||
|
Global intangible low-taxed income
|
474 | 0.3 | ||||||
|
Foreign derived intangible income
|
(2,175 | ) | (1.2 | ) | ||||
|
Other effects of cross-border taxes
|
733 | 0.4 | ||||||
| Nontaxable or nondeductible items |
||||||||
|
Nondeductible compensation
|
2,452 | 1.4 | ||||||
|
Other nontaxable or nondeductible items
|
(155 | ) | (0.1 | ) | ||||
| Changes in unrecognized benefits |
198 | 0.1 | ||||||
| Other reconciling items |
319 | 0.2 | ||||||
| Effective taxes and tax rate |
$ | 43,058 | 24.3 | % | ||||
|
|
2024
|
2023
|
||||||
|
Taxes at statutory rate
|
21.0
|
%
|
21.0
|
%
|
||||
|
State income taxes, net of federal income tax benefit
|
1.0
|
1.1
|
||||||
|
Tax credits
|
(1.6
|
)
|
(1.9
|
)
|
||||
|
Taxes on foreign earnings
|
4.1
|
4.8
|
||||||
|
Global Intangible Low-Taxed Income
|
0.5
|
0.6
|
||||||
|
Foreign Derived Intangible Income
|
(1.2
|
)
|
(1.3
|
)
|
||||
|
Resolution of prior years’ tax matters
|
0.6
|
0.3
|
||||||
|
Valuation allowance adjustments
|
(1.4
|
)
|
2.8
|
|||||
| Nondeductible compensation |
0.9 | 1.2 | ||||||
|
Other, net
|
(0.5
|
)
|
(0.5
|
)
|
||||
|
Effective tax rate
|
23.4
|
%
|
28.1
|
%
|
||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Deferred tax assets:
|
||||||||
|
Benefit plans
|
$
|
10,859
|
$
|
8,123
|
||||
|
Liabilities and reserves
|
20,886
|
20,322
|
||||||
|
Operating loss and credit carryovers
|
58,598
|
59,834
|
||||||
|
Capitalized research and development costs
|
22,745 | 18,666 | ||||||
|
Other
|
20,788
|
5,355
|
||||||
|
Gross deferred tax assets
|
133,876
|
112,300
|
||||||
|
Valuation allowance
|
(29,053
|
)
|
(29,743
|
)
|
||||
|
Deferred tax assets
|
104,823
|
82,557
|
||||||
|
Deferred tax liabilities:
|
||||||||
|
Property, plant, and equipment
|
(28,265
|
)
|
(26,092
|
)
|
||||
|
Goodwill
|
(19,005
|
)
|
(20,685
|
)
|
||||
|
Deferred tax liabilities
|
(47,270
|
)
|
(46,777
|
)
|
||||
|
Net deferred tax assets
|
$
|
57,553
|
$
|
35,780
|
||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Balance at beginning of year
|
$
|
4,391
|
$
|
4,251
|
||||
|
Increases for tax positions taken in the current year
|
840
|
865
|
||||||
| Increases for tax positions taken in prior years | 130 | 422 | ||||||
|
Decreases related to settlements with tax authorities
|
(736
|
)
|
-
|
|||||
|
Decreases as a result of lapse of the applicable statutes of limitations
|
(952
|
)
|
(765
|
)
|
||||
|
Foreign currency exchange rate changes
|
457
|
(382
|
)
|
|||||
|
Balance at the end of year
|
$
|
4,130
|
$
|
4,391
|
||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 13, 2026 | Showing above |
| 2017 | Feb 23, 2018 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.